Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 6, 2011, Pages 400-407

  Enrique, Diaz Guzman ^a   Khosravi, Mehdi ^a   Mannino, David M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Airflow obstruction; Asthma; COPD; Mortality; Overlap

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; LUNG FUNCTION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; SMOKING; SURVIVAL; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SMOKING; SPIROMETRY; UNITED STATES;

EID: 83155164527     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.611200     Document Type: Article

References (31)

1. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007 Sep 1; 370(9589):765-773. (Pubitemid 47321908)
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002 Oct; 47(10):1184-1199.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.NHLBI/WHOGlobal Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 Apr; 163(5):1256-1276. (Pubitemid 32378468)
4. Celli BR,MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6):932-946. (Pubitemid 38807371)
5. Barnes PJ, Kleinert S. COPD-a neglected disease. Lancet 2004 Aug 14-20; 364(9434):564-565.
6. Decramer M, Sibille Y. European conference on chronic respiratory disease. Lancet 2011 Jan 8; 377(9760):104-106.
7. WHO. World health statistics. http:\\www.whoint/whosis /whostat/EN WHS08 Full.pdf (accessed Jan 31, 2011) 2008.
8. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 May; 59(5):469-478. (Pubitemid 38580764)
9. Akinbami LJ, Moorman JE, Liu X. Asthma Prevalence, Health Care Use and Mortality, United States: 2005-2009. 2011.
10. Anandan C,NurmatovU, van SchayckOC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010 Feb; 65(2):152-167.
11. Soriano JB,Davis KJ, Coleman B, Visick G,Mannino D, PrideNB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003 Aug; 124(2):474-481. (Pubitemid 37000122)
12. Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008 Jul; 134(1):14-19. (Pubitemid 352008758)
13. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax 2009 Aug; 64(8):728-735.
14. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999 Jan; 159(1):179-187. (Pubitemid 29036522)
15. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176(6):532-555. (Pubitemid 47403272)
16. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of the Ciba guest symposium. Thorax 1959(14):286-299.
17. Viegi G, Matteelli G, Angino A, Scognamiglio A, Baldacci S, Soriano JB, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest 2004 Oct; 126(4):1093-1101
18. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009 Oct; 34(4):812-818.
19. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008 Mar; 14(2):176-185. (Pubitemid 351453818)
20. Meyer PA, Mannino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest 2002 Dec; 122(6):2003-2008. (Pubitemid 36051136)
21. Bumbacea D,Campbell D,Nguyen L,Carr D, Barnes PJ, Robinson D, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004 Jul; 24(1):122-128. (Pubitemid 39029077)
22. Panizza JA, James AL, Ryan G, de Klerk N, Finucane KE. Mortality and airflow obstruction in asthma: a 17-year follow-up study. Intern Med J 2006 Dec; 36(12):773-780. (Pubitemid 44691185)
23. SilvaGE, SherrillDL,Guerra S, Barbee RA.Asthma as a risk factor for COPD in a longitudinal study. Chest 2004 Jul; 126(1):59-65. (Pubitemid 38943118)
24. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010 Sep 4; 376(9743):803-813.
25. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003 Oct 9; 349(15):1414-22. (Pubitemid 37211056)
26. Camilli AE, Burrows B, Knudson RJ, Lyle SK, LebowitzMD. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987 Apr; 135(4):794-799. (Pubitemid 17055503)
27. Soriano JB, Vestbo J, Pride NB, Kiri V,Maden C,MaierWC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819-825. (Pubitemid 35175115)
28. Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, et al. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. Respir Med 2006 Apr; 100(4):595-609. (Pubitemid 43285746)
29. Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. COPD 2007 Jun; 4(2):127-134 (Pubitemid 47164864)
30. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007 Dec; 132(6):1748-1755.
31. Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Cost and utilization of COPD and asthma among insured adults in the US. Curr Med Res Opin 2009 Jun; 25(6):1385-1392.